Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 5;32(6):1602-1603.
doi: 10.1016/j.ymthe.2024.05.010. Epub 2024 May 21.

Targeting astrocytes with in vivo gene addition: Can it rescue loss of brain myelin?

Yi Gong  1 , Florian S Eichler  2
Affiliations

Targeting astrocytes with in vivo gene addition: Can it rescue loss of brain myelin?

Yi Gong et al. Mol Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Herstine J.A., Chang P.K., Chornyy S., Stevenson T.J., Sunshine A.C., Nokhrina K., Rediger J., Wentz J., Vetter T.A., Scholl E., et al. Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease. Mol. Ther. 2024;32:1701–1720. doi: 10.1016/j.ymthe.2024.03.034. - DOI - PubMed
    1. Scali O., Di Perri C., Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol. Sci. 2006;27:271–277. - PubMed
    1. Bugiani M., Boor I., Powers J.M., Scheper G.C., van der Knaap M.S. Leukoencephalopathy With Vanishing White Matter: A Review. J. Neuropathol. Exp. Neurol. 2010;69:987–996. - PubMed
    1. Herzog R.W., Hagstrom J.N., Kung S.H., Tai S.J., Wilson J.M., Fisher K.J., High K.A. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 1997;94:5804–5809. - PMC - PubMed
    1. Niemeyer G.P., Herzog R.W., Mount J., Arruda V.R., Tillson D.M., Hathcock J., van Ginkel F.W., High K.A., Lothrop C.D., Jr. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood. 2009;113:797–806. - PMC - PubMed

LinkOut - more resources